{"disease":{"id":"glomerular-nephritis","name":"glomerular nephritis"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06065852","title":"National Registry of Rare Kidney Diseases","phase":"","overall_status":"RECRUITING","enrollment_count":35000,"lead_sponsor_name":"UK Kidney Association","has_results":false},{"nct_id":"NCT03929887","title":"KOrea Renal Biobank NEtwoRk System TOward NExt-generation Analysis","phase":"","overall_status":"RECRUITING","enrollment_count":3000,"lead_sponsor_name":"Seoul National University Hospital","has_results":false},{"nct_id":"NCT03460054","title":"The Canadian Glomerulonephritis Registry and Translational Research Initiative","phase":"","overall_status":"UNKNOWN","enrollment_count":300,"lead_sponsor_name":"University Health Network, Toronto","has_results":false},{"nct_id":"NCT06858319","title":"Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":220,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":false},{"nct_id":"NCT00977977","title":"Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":30,"lead_sponsor_name":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","has_results":false},{"nct_id":"NCT02765789","title":"Immunoadsorption in Anti-GBM Glomerulonephritis.","phase":"NA","overall_status":"COMPLETED","enrollment_count":8,"lead_sponsor_name":"University Medical Center Groningen","has_results":false}],"total":6},"guidelines":[],"source":"Drug Landscape verified database"}